Differential genomic profiling of progesterone receptor (PR) negative, estrogen receptor (ER) positive HER2-negative metastatic breast cancer (MBC) through circulating tumor DNA

被引：0
|
作者：
Gerratana, Lorenzo
Davis, Andrew
Medford, Arielle
Reduzzi, Carolina
Clifton, Katherine
Podany, Emily
Hensing, Whitney
Velimirovic, Marko
Shah, Ami N.
Foffano, Lorenzo
Arcos, Laura Munoz
Nicolo, Eleonora
Dai, Charles S.
Keenan, Jennifer
Behdad, Amir
Wander, Seth
Gradishar, William
Ma, Cynthia
Puglisi, Fabio
Bardia, Aditya
Cristofanilli, Massimo
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-15-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-15-04
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Hormone receptor-positive, HER2-negative metastatic breast cancer: redrawing the lines
    Matutino, A.
    Joy, A. A.
    Brezden-Masley, C.
    Chia, S.
    Verma, S.
    CURRENT ONCOLOGY, 2018, 25 : S131 - S141
  • [32] Clinical outcomes of estrogen receptor (ER)-negative and progesterone receptor (PgR)-positive invasive breast cancer
    Chan, Melissa
    Chang, Martin
    Gonzalez, Rosa
    Lategan, Belinda
    del Barco, Elvira
    Vera-Badillo, Francisco Emilio
    Quesada, Paula
    Goldstein, Robyn
    Cruz, Ignacio
    Ocana, Alberto
    Cruz, Juan J.
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Exploratory biomarker analysis in VERONICA, a phase 2 study of venetoclax plus fulvestrant versus fulvestrant in patients with estrogen receptor (ER)-positive HER2-negative metastatic breast cancer (mBC)
    Lindeman, Geoffrey J.
    Fernando, Tharu M.
    Bowen, Rebecca
    Chang, Ching-Wei
    Desai, Rupal
    Gupta, Kushagra
    Flechais, Aulde
    Wilson, Timothy R.
    Bardia, Aditya
    CANCER RESEARCH, 2022, 82 (04)
  • [34] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Wu, Lunpo
    Wang, Qinghua
    Zhou, Shishi
    Tang, Wanfen
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Hong, Zhongwu
    Fu, Jianfei
    Du, Jinlin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1145 - 1153
  • [35] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Hongjuan Zheng
    Chenyang Ge
    Haiping Lin
    Lunpo Wu
    Qinghua Wang
    Shishi Zhou
    Wanfen Tang
    Xia Zhang
    Xiayun Jin
    Xifeng Xu
    Zhongwu Hong
    Jianfei Fu
    Jinlin Du
    International Journal of Clinical Oncology, 2022, 27 : 1145 - 1153
  • [36] Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
    Bauer, Katrina R.
    Brown, Monica
    Cress, Rosemary D.
    Parise, Carol A.
    Caggiano, Vincent
    CANCER, 2007, 109 (09) : 1721 - 1728
  • [37] Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
    Reinert, Tomas
    de Paula, Bruno
    Shafaee, Maryam Nemati
    Souza, Pedro Henrique
    Ellis, Matthew J.
    Bines, Jose
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [38] Circulating tumor DNA dynamics in acelERA Breast Cancer: a Phase II study of giredestrant for estrogen receptor-positive, HER2-negative, previously treated advanced breast cancer
    Collier, Ann
    Bardia, Aditya
    Sohn, Joo Hyuk
    Lim, Elgene
    Chavez, Marianna
    Martin, Miguel
    Martinalbo, Jorge
    Perez-Moreno, Pablo
    Moore, Heather
    CANCER RESEARCH, 2024, 84 (09)
  • [39] PROGESTERON RECEPTOR STATUS IN DETERMINING THE PROGNOSIS OF ESTROGEN RECEPTOR POSITIVE/HER2-NEGATIVE BREAST CARCINOMA
    Arslan, U. Yalcintas
    Bal, O.
    Ozatli, T.
    Helvaci, K.
    Esbah, O.
    Budakoglu, B.
    Uyeturk, U.
    Sonmez, O. U.
    Turker, I.
    Oksuzoglu, O. B.
    ANNALS OF ONCOLOGY, 2012, 23 : 105 - 105
  • [40] The natural history of untreated estrogen receptor-positive, Her2-negative invasive breast cancer
    Kristin E. Rojas
    Donna-Marie Manasseh
    Mary Rojas
    Andrea Mattocks
    Leah Portnow
    Sarah Kantharia
    Natalie Zelenko
    Christina Giuliano
    Patrick I. Borgen
    Breast Cancer Research and Treatment, 2020, 182 : 79 - 83
12345